B7-H3 in Cancer Immunotherapy—Prospects and Challenges: A Review of the Literature

In today’s oncology, immunotherapy arises as a potent complement for conventional cancer treatment, allowing for obtaining better patient outcomes. B7-H3 (CD276) is a member of the B7 protein family, which emerged as an attractive target for the treatment of various tumors. The molecule modulates an...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sylwia Mielcarska, Anna Kot, Miriam Dawidowicz, Agnieszka Kula, Piotr Sobków, Daria Kłaczka, Dariusz Waniczek, Elżbieta Świętochowska
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-08-01
Edice:	Cells
Témata:	B7-H3 (CD276) immune checkpoint solid tumors B7-H3 clinical trials
On-line přístup:	https://www.mdpi.com/2073-4409/14/15/1209
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!